Gut Microbiota‐Induced CTLA4 Expression on CD8 + T Cells Impairs Antitumor Immunity and Promotes Colorectal Cancer Progression
Immunology · 2026
DOI: 10.1111/imm.70128 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunology, 2026. Verfasst von Meidie Cheng und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Science and Engineering, Henan University of Urban Construction, Pingdingshan, China. Hauptthemen laut MEDLINE: CTLA-4 Antigen, Colorectal Neoplasms, Gastrointestinal Microbiome, CD8-Positive T-Lymphocytes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 125 Literaturangaben. Gefördert von: The Key Scientific Research Project Plan of Higher Education Institutions in Henan Province, The Youth Fund of Natural Science Foundation of Henan Province.
Abstract (Originalsprache)
This study reveals a novel gut microbiota‐CD8 + T cell axis driving immunosuppression in colorectal cancer. Analysis of 16S rRNA sequencing identified significant gut dysbiosis in CRC patients, with marked enrichment of Phocaeicola and Bacteroides. Single‐cell transcriptomics uncovered substantial T cell depletion and elevated CTLA4 + PD1 + immune cells within the tumour microenvironment. Critically, spatial transcriptomics demonstrated co‐localization of CTLA4 + CD8 + T cells with tumour cells, indicating direct immunosuppressive interactions. Functional validation confirmed CTLA4 overexpression impairs CD8 + T cell effector capacity, accelerating CRC cell proliferation and invasion. In vivo models demonstrated that faecal microbiota transplantation (FMT) promoted CTL activation, reduced Bacteroides abundance, decreased the formation of CD8 + CTLA4 + T cells and ameliorated CRC symptoms. Additionally, CTLA4 knockdown inhibited tumour growth and metastasis. These findings establish a mechanistic pathway: gut dysbiosis induces chronic inflammation, triggering CTLA4 upregulation on CD8 + T cells to promote T cell exhaustion and tumour immune evasion. The study provides immunological evidence for targeting the microbiota‐CTLA4 axis in CRC immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Life Science and Engineering, Henan University of Urban Construction, Pingdingshan, China.
ORCID-Profile: Meidie Cheng
Förderung
- The Key Scientific Research Project Plan of Higher Education Institutions in Henan Province
- The Youth Fund of Natural Science Foundation of Henan Province
Zitieren
APA
Cheng, M., Zhi, S., Zheng, M., Zhang, S., & Hong, J. (2026). Gut Microbiota‐Induced CTLA4 Expression on CD8 + T Cells Impairs Antitumor Immunity and Promotes Colorectal Cancer Progression. Immunology. https://doi.org/10.1111/imm.70128
Vancouver
Cheng M, Zhi S, Zheng M, Zhang S, Hong J. Gut Microbiota‐Induced CTLA4 Expression on CD8 + T Cells Impairs Antitumor Immunity and Promotes Colorectal Cancer Progression. Immunology. 2026. doi:10.1111/imm.70128
BibTeX
@article{Cheng2026,
author = {Cheng, Meidie and Zhi, Shuangcheng and Zheng, Mengmeng and Zhang, Sijin and Hong, Jun},
title = {Gut Microbiota‐Induced CTLA4 Expression on CD8 + T Cells Impairs Antitumor Immunity and Promotes Colorectal Cancer Progression},
journal = {Immunology},
year = {2026},
doi = {10.1111/imm.70128}
}
EUVIMED